[go: up one dir, main page]

PE20010405A1 - DERIVADOS DE 1,2,3,4,5,6-HEXAHIDROAZEPIN[4,5-b]INDOLES 9-ARILSULFONA CON AFINIDAD SOBRE EL RECEPTOR 5HT6 - Google Patents

DERIVADOS DE 1,2,3,4,5,6-HEXAHIDROAZEPIN[4,5-b]INDOLES 9-ARILSULFONA CON AFINIDAD SOBRE EL RECEPTOR 5HT6

Info

Publication number
PE20010405A1
PE20010405A1 PE2000000696A PE0006962000A PE20010405A1 PE 20010405 A1 PE20010405 A1 PE 20010405A1 PE 2000000696 A PE2000000696 A PE 2000000696A PE 0006962000 A PE0006962000 A PE 0006962000A PE 20010405 A1 PE20010405 A1 PE 20010405A1
Authority
PE
Peru
Prior art keywords
hexahidroazepin
alkyl
indol
phenyl
indoles
Prior art date
Application number
PE2000000696A
Other languages
English (en)
Inventor
E Jon Jacobsen
Susan K Hendges
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PE20010405A1 publication Critical patent/PE20010405A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/36Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/01Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton
    • C07C323/09Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton having sulfur atoms of thio groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A DERIVADOS 1,2,3,4,5,6-HEXAHIDROAZEPIN[4,5-b]INDOLES 9-ARILSULFONAS SUSTITUIDOS DE FORMULA XII, DONDE: R3 ES H, ALQUILO C1-C4, FENILO OPCIONALMENTE SUSTITUIDO CON F, Cl, Br, I, O-R(3-1), CF3, CONR(3-2)R(3-3), NH-SO2-R(3-4); R(3-1) ES H, ALQUILO C1-C4, FENILO; R(3-2) Y R(3-3) SON H, ALQUILO C1-C4; R(3-2) Y R(3-3) JUNTO A N FORMAN 1-PIRROLIDINILO, 1-PIPERAZINILO, 1-MORFOLINILO, ENTRE OTROS; RN ES H, ALQUILO C1-C4, FENILO, CF3, CO-NR(N-2)R(N-3); R(N-2) Y R(N-3) SON H, ALQUILO C1-C4; R(3-2) Y R(3-3) JUNTO A N FORMAN 1-PIRROLIDINILO, 1-PIPERAZINILO, 1-MORFOLINILO, ENTRE OTROS; RX ES H, F, Cl, Br, I, -O-R(X-1), CF3, CONR(X-2)R(X-3), NHSO2R(X-4), ENTRE OTROS; R(X-1) ES H, ALQUILO C1-C4, FENILO, ENTRE OTROS; R9 ES H, F, Cl, ALQUILO C1-C4, ALCOXILO C1-C3, CF3, ENTRE OTROS. SON COMPUESTOS PREFERIDOS 9-(FENILSULFONIL)-1,2,3,4,5,6-HEXAHIDROAZEPIN[4,5-b]INDOL, 9-[(4-FLUOROFENIL)SULFONIL]-1,2,3,4,5,6-HEXAHIDROAZEPIN[4,5-b]INDOL, 9-[(3,4-DIFLUOROFENIL)SULFONIL]-1,2,3,4,5,6-HEXAHIDROAZEPIN[4,5-b]INDOL, CLORHIDRATO DE 6-METIL-9-[(4-TRIFLUOROMETILFENIL)SULFONIL]-1,2,3,4,5,6-HEXAHIDROAZEPIN-[4,5-b]INDOL, ENTRE OTROS. LAS 9-ARILSULFONAS PUEDEN SER UTILES PARA TRATAR ANSIEDAD, DEPRESION, ESQUIZOFRENIA, ESTRES, PANICO, OBESIDAD
PE2000000696A 1999-07-19 2000-07-13 DERIVADOS DE 1,2,3,4,5,6-HEXAHIDROAZEPIN[4,5-b]INDOLES 9-ARILSULFONA CON AFINIDAD SOBRE EL RECEPTOR 5HT6 PE20010405A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14457499P 1999-07-19 1999-07-19

Publications (1)

Publication Number Publication Date
PE20010405A1 true PE20010405A1 (es) 2001-03-28

Family

ID=22509195

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000696A PE20010405A1 (es) 1999-07-19 2000-07-13 DERIVADOS DE 1,2,3,4,5,6-HEXAHIDROAZEPIN[4,5-b]INDOLES 9-ARILSULFONA CON AFINIDAD SOBRE EL RECEPTOR 5HT6

Country Status (15)

Country Link
US (4) US6468999B1 (es)
EP (1) EP1196417B8 (es)
JP (1) JP2003505391A (es)
AR (1) AR024773A1 (es)
AT (1) ATE293626T1 (es)
AU (1) AU774794C (es)
CA (1) CA2377718A1 (es)
CO (1) CO5190715A1 (es)
DE (1) DE60019599T2 (es)
ES (1) ES2241624T3 (es)
MY (1) MY122278A (es)
NZ (1) NZ516677A (es)
PE (1) PE20010405A1 (es)
WO (1) WO2001005793A1 (es)
ZA (1) ZA200110536B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7016870B1 (en) 1997-12-02 2006-03-21 Financial Engines Identifying a recommended portfolio of financial products for an investor based upon financial products that are available to the investor
US6292787B1 (en) 1998-09-11 2001-09-18 Financial Engines, Inc. Enhancing utility and diversifying model risk in a portfolio optimization framework
WO2001063458A2 (en) 2000-02-23 2001-08-30 Financial Engines, Inc. Load aware optimization
JP2004509894A (ja) 2000-09-20 2004-04-02 ファルマシア・アンド・アップジョン・カンパニー 置換アゼピノ[4,5−b]インドリン誘導体
US20020160999A1 (en) * 2001-01-08 2002-10-31 Jacobsen Susan Fox Substituted indolines
EP1411925A1 (en) * 2001-08-03 2004-04-28 PHARMACIA & UPJOHN COMPANY 5-arylsulfonyl indoles having 5-ht6 receptor affinity
US8200561B1 (en) 2002-03-29 2012-06-12 Financial Engines, Inc. Tax-aware asset allocation
TWI329111B (en) 2002-05-24 2010-08-21 X Ceptor Therapeutics Inc Azepinoindole and pyridoindole derivatives as pharmaceutical agents
US7595311B2 (en) 2002-05-24 2009-09-29 Exelixis, Inc. Azepinoindole derivatives as pharmaceutical agents
US20040248880A1 (en) * 2003-04-25 2004-12-09 Jacobsen Eric Jon 1,2,3,4,5,6-Hexahydroazepino[4,5-B]indoles containing arylsulfones at the 9-position
US8466143B2 (en) 2003-07-23 2013-06-18 Exelixis, Inc. Azepine derivatives as pharmaceutical agents
JP5420908B2 (ja) * 2005-12-15 2014-02-19 エグゼリクシス, インコーポレイテッド 医薬的薬剤としてのアゼピノインドール誘導体
EP2476680B1 (en) 2008-01-11 2014-08-27 Albany Molecular Research, Inc. (1-Azinone)-Substituted Pyridoindoles
AU2009308708B2 (en) * 2008-10-31 2015-11-19 Medivation Technologies, Inc. Azepino [4, 5-b] indoles and methods of use
US9073925B2 (en) 2009-07-01 2015-07-07 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
US8618299B2 (en) 2009-07-01 2013-12-31 Albany Molecular Research, Inc. Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof
JP2012532144A (ja) 2009-07-01 2012-12-13 アルバニー モレキュラー リサーチ, インコーポレイテッド アジノン置換アゼピノ[b]インドールおよびピリド−ピロロ−アゼピンmch−1拮抗薬、ならびにその作製方法および使用
WO2011003007A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2012088038A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
US8993765B2 (en) 2010-12-21 2015-03-31 Albany Molecular Research, Inc. Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
WO2018064465A1 (en) 2016-09-29 2018-04-05 The Regents Of The University Of California Compounds for increasing neural plasticity
CA3130770A1 (en) 2019-02-27 2020-09-03 The Regents Of The University Of California Azepino-indoles and other heterocycles for treating brain disorders
WO2023092045A1 (en) 2021-11-17 2023-05-25 Terran Biosciences, Inc. Salt and solid forms of tabernanthalog
TW202333668A (zh) 2021-12-15 2023-09-01 美商德利克斯醫療公司 經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1489916A (fr) 1965-07-20 1967-07-28 Bayer Ag Procédé de préparation d'aminophényl-thioéthers
CH462847A (de) 1965-11-11 1968-09-30 Agripat Sa Verfahren zur Herstellung von halogenierten Nitranilinen
GR35044B (el) 1966-05-10 1968-07-31 The Upjohn Company Μεθοδος παρασκευης οργανικων ενωσεων.
US3839357A (en) 1966-05-10 1974-10-01 Upjohn Co 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles
US3576872A (en) 1968-05-03 1971-04-27 Exxon Research Engineering Co Herbicidal s-aryl arylamides
GB1293540A (en) 1968-12-31 1972-10-18 Coalite Chem Prod Ltd Preparation of diaryl ethers and thioethers
NL7008628A (es) 1969-06-25 1970-12-29
US3652588A (en) * 1969-10-23 1972-03-28 Upjohn Co 6-alkyl-1 2 3 4 5 6-hexahydroazepino(4 5-b)indoles
US3676558A (en) 1970-08-28 1972-07-11 Upjohn Co Anorexigenic compositions comprising 6-alkyl-1,2,3,4,5,6-hexahydroazepino 4,5-indoles as active ingredient and process of treatment
DE2149645A1 (de) 1970-10-07 1972-09-14 Pfizer 2-Phenyl-as-triazin-3.5-(2H,4H)-dione und die Verwendung dieser Verbindungen zur Bekaempfung der Coccidiose
FR2135740A5 (en) 1971-04-26 1972-12-22 Exxon Research Engineering Co Herbicidal s-aryl arylamides
DE2120708A1 (en) 1971-04-27 1972-11-09 Esso Research and Engineering Co., Linden, NJ. (V.St.A.) Herbicidal s-aryl arylamides
SU380644A1 (ru) 1971-05-18 1973-05-15 Институт естественных наук Бур тского филиала Сибирского отделени СССР Способ получения 3,4,4'-триаминодифенилсульфона
CS149525B1 (es) 1971-07-22 1973-07-25
US3914418A (en) * 1971-09-02 1975-10-21 Merck & Co Inc Methods of controlling liver fluke infections
BE789138A (fr) 1971-09-24 1973-03-22 Bayer Ag Nouveaux derives triazeniques, leur procede de preparation et medicament les contenant
SU436817A1 (ru) 1972-04-03 1974-07-25 Всесоюзный Научно-Исследовательский И Проектный Институт Мономеров Способ получени 2,4-динитро-5-амино-1-х-производных бензола
SU475382A1 (ru) 1972-12-19 1975-06-30 Предприятие П/Я В-2304 Огнестойка полимерна композици
DE2313721A1 (de) 1973-03-20 1974-10-03 Bayer Ag Neue 1-phenylsubstituierte 1,3,5triazine, verfahren zu ihrer herstellung, sowie ihre verwendung als arzneimittel
US3948987A (en) 1974-04-19 1976-04-06 Minnesota Mining And Manufacturing Company Substituted methanesulfonanilides
DE2438099A1 (de) 1974-08-08 1976-02-19 Bayer Ag Substituierte benzothiadiazinyl-carbamidsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2438120A1 (de) 1974-08-08 1976-02-19 Bayer Ag Substituierte benzimidazolylcarbamidsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4239888A (en) 1974-11-04 1980-12-16 Pfizer Inc. 1-Phenyluracils
DE2509037A1 (de) 1975-03-01 1976-09-02 Bayer Ag 1-aryluracile, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
ZA763751B (en) 1975-06-23 1978-02-22 Syntex Inc 7(8)-substituted triazinobenzimidazoles having antifungal and anthelmintic activity
US4026830A (en) 1975-08-18 1977-05-31 The United States Of America As Represented By The Secretary Of The Navy Poly[tantalum phosphinates]
DE2548910A1 (de) 1975-10-31 1977-05-12 Bayer Ag Neue acylaminonitrobenzol-derivate und verfahren zu ihrer herstellung
CH619460A5 (en) 1976-01-14 1980-09-30 Ciba Geigy Ag Process for the preparation of quinoxaline di-N-oxide derivatives
GB1561230A (en) 1976-02-23 1980-02-13 Sankio Chemical Co Ltd Aminothiofluoran compounds process for the production thereof and recording elements containing the same
DE2748978A1 (de) 1977-11-02 1979-05-03 Basf Ag Azofarbstoffe
GR73690B (es) 1979-01-15 1984-04-02 Celamerck Gmbh & Co Kg
DE2916135A1 (de) 1979-04-20 1980-10-30 Bayer Ag Neue, schwefelhaltige diisocyanate, ein verfahren zu ihrer herstellung, sowie ihre verwendung als aufbaukomponente bei der herstellung von polyurethanen
US4298676A (en) 1979-10-29 1981-11-03 Polaroid Corporation Optical filter agents and photographic products and processes containing same
EP0028381B1 (en) * 1979-11-02 1985-04-10 Sandoz Ag Azepinoindoles, process for their production and pharmaceutical compositions containing them
US4332820A (en) 1980-01-25 1982-06-01 The Dow Chemical Company Substituted benzonitriles having antiviral activity
DE3008985A1 (de) 1980-03-08 1981-10-01 Basf Ag, 6700 Ludwigshafen N-aryl(thiol)carbamate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
DE3027530A1 (de) 1980-07-19 1982-02-25 Dr. Karl Thomae Gmbh, 7950 Biberach Neue lactame, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3367327D1 (en) * 1982-08-06 1986-12-11 American Cyanamid Co Method of modulating the immune response system in mammals
CS229033B1 (cs) 1982-09-28 1984-05-14 Horyna Jaroslav Způsob parciální redukce dinitrodifenylsulfidů, -sulfoxidů a -sulfonů
JPS6044557A (ja) 1983-08-22 1985-03-09 Nippon Kayaku Co Ltd 不溶性モノアゾ化合物及びそれを用いる染色法
US4904794A (en) 1987-03-05 1990-02-27 Ciba-Geigy Corporation Pyrazoline compounds
EP0354303A1 (en) 1988-05-19 1990-02-14 American Cyanamid Company Amidines of diphenyl sulfones, their derivatives and their use
JPH0248564A (ja) 1988-08-10 1990-02-19 Sumitomo Seika Chem Co Ltd 核置換チオフェノール誘導体の製造方法
US4894358A (en) * 1988-08-31 1990-01-16 Polaroid Corporation Thermal imaging with ylide dyes
DE3831445C2 (de) 1988-09-13 1998-09-10 Joachim K Prof Dr Seydel Verwendung von substituierten 2,4-Diamino-5-benzylpyrimidinen gegebenenfalls in Kombination mit 4,4'-Diaminodiphenylsulfonen zur Behandlung von Malaria
GB8914660D0 (en) * 1989-06-26 1989-08-16 Fujisawa Pharmaceutical Co Aniline derivatives,processes for production thereof and pharmaceutical compositions comprising the same
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
AU5285993A (en) 1992-10-21 1994-05-09 Mitsui Petrochemical Industries, Ltd. N-t-butylaniline analog and lipid level depressant containing the same
IL108630A0 (en) * 1993-02-18 1994-05-30 Fmc Corp Insecticidal substituted 2,4-diaminoquinazolines
AU7340696A (en) 1995-10-09 1997-04-30 Chong Kun Dang Corporation Sulfoxide derivatives of nitrogen-mustard and anticancer agent containing the same
KR0183826B1 (ko) 1996-03-04 1999-05-01 김광호 연마공정 후처리용 세정 용액 및 그를 이용하는 세정 방법
US5952349A (en) 1996-07-10 1999-09-14 Schering Corporation Muscarinic antagonists for treating memory loss
DE19654445A1 (de) 1996-12-31 1998-07-02 Seydel Joachim K Prof Dr Verwendung von substituierten 4-Aminodiphenylsulfonen zur Behandlung von entzündlichen Erkrankungen
EP1042305B1 (en) * 1997-12-22 2005-06-08 Bayer Pharmaceuticals Corp. INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
ES2193607T3 (es) 1998-01-16 2003-11-01 Hoffmann La Roche Derivados de benzosulfona .
GB9804648D0 (en) * 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9811427D0 (en) * 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
DE19829357A1 (de) * 1998-07-01 2000-01-05 Bayer Ag Verfahren zur Herstellung von 2-Nitro-5-(phenylthio)-anilinen

Also Published As

Publication number Publication date
US6468999B1 (en) 2002-10-22
AU774794C (en) 2005-04-14
US20020128475A1 (en) 2002-09-12
US20020156275A1 (en) 2002-10-24
JP2003505391A (ja) 2003-02-12
AR024773A1 (es) 2002-10-23
US20020111483A1 (en) 2002-08-15
WO2001005793A1 (en) 2001-01-25
DE60019599D1 (de) 2005-05-25
US6921823B2 (en) 2005-07-26
ZA200110536B (en) 2003-03-24
AU6049700A (en) 2001-02-05
MY122278A (en) 2006-04-29
NZ516677A (en) 2003-11-28
AU774794B2 (en) 2004-07-08
CO5190715A1 (es) 2002-08-29
EP1196417B8 (en) 2005-06-15
EP1196417A1 (en) 2002-04-17
ES2241624T3 (es) 2005-11-01
ATE293626T1 (de) 2005-05-15
CA2377718A1 (en) 2001-01-25
DE60019599T2 (de) 2006-03-02
US6878823B2 (en) 2005-04-12
EP1196417B1 (en) 2005-04-20

Similar Documents

Publication Publication Date Title
PE20010405A1 (es) DERIVADOS DE 1,2,3,4,5,6-HEXAHIDROAZEPIN[4,5-b]INDOLES 9-ARILSULFONA CON AFINIDAD SOBRE EL RECEPTOR 5HT6
WO2008088692A3 (en) Spirochromanon derivatives
ES2271615T3 (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados y su uso como antibacterianos.
AR051461A1 (es) Compuesto de pirazolo[1,5-a]pirimidin-7-il-amina forma poliformica 1 de [3-(4-metoxi-2-metil-fenil)-2,5-dimetil-pirazolo[1,5-a]pirimidin-7-il]-[(s)-1-(3-metil-[1,2,4]oxadiazol-5-il)-propil]-amina, composicion farmaceutica que lo comprende y su uso para prepararla
PE20060842A1 (es) Amino-imidazolonas para la inhibicion de b-secretasa
AR015595A1 (es) Compuestos derivados de pirazolo [4,3-d]-pirimidin-7-onas, composiciones farmaceuticas, formulacion veterinaria, uso de dichos compuestos en la preparacionde composicion y formulaciones. procedimientos para su uso, compuestos intermediarios, proceso para la preparacion de los compuestos.
MX2009007502A (es) Derivados de espirocromanona sustituidos.
AU2003217936A1 (en) Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
PE20030129A1 (es) Imidazotriazinas
DK1404317T3 (da) 5-Halogentryptaminderivater til anvendelse som ligander af 5-HT6- og/eller 5-HT7-serotoninreceptorer
PE20050896A1 (es) Intermediarios de quinolina como inhibidores de tirosina quinasas de receptores y la sintesis de los mismos
PE20120655A1 (es) Derivados de triazolopiridina como inhibidores de proteinas cinasas activadas por mitogeno p38 (map)
PE20040197A1 (es) Pirazolopiridinas sustituidas con carbamato
AR036093A1 (es) Compuestos derivados de tiazolidinilo, pirrolidinilo, oxazolidinilo, piperidilo, morfolinilo y tiomorfolinilo, su uso, composiciones farmaceuticas que los comprenden, y compuestos intermediarios
CO5080744A1 (es) Ligandos de alta afinidad para el receptor de nociceptina orl-1
PE20010401A1 (es) DERIVADOS DE 8-FENIL-6,9-DIHIDRO-[1,2,4] TRIAZOL [3,4-i] PURIN-5-ONA COMO INHIBIDORES DE FOSFODIESTERASA ESPECIFICA DE GMP CICLICO
PE20020524A1 (es) 7-oxo-piridopirimidinas como inhibidores de quinasas
AR008177A1 (es) Nuevas bisindolilmaleimidas, sales de las mismas, procesos para su preparacion intermediarios, su uso para la fabricacion de medicamentos, metodode tratamiento y composicion farmaceutica.
ECSP088105A (es) Derivados de n-(arilalquil)-1h-pirrolopiridin-2-carboxamidas, su preparación y su aplicación en terapéutica
ATE23860T1 (de) Imidazo(1,2-a)pyridine, ihre herstellung und therapeutische verwendung.
MX20222A (es) Tetrahidrobenzo (c,d)indoles y procedimiento para su preparacion.
DK1204662T3 (da) Azaindoler med serotoninreceptoraffinitet
ZA200503231B (en) 3-Phenyl substituted pyridoindolone, preparation and therapeutic use thereof
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
AR041405A1 (es) Derivados de (+) - trans - isomeros de ( 1- fosfonometoxi - 2 alquiciclopropil) metil nucleosido, un procedimiento para la preparacion de esteroisomeros de los mismos y utilizacion de agentes antivirales de los mismos

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed